Digital Health Startups

Flok Health builds AI systems for healthcare applications. The company serves the healthcare industry with regulated AI solutions backed by founders with deep expertise in healthtech, engineering, and AI systems.

3 investors

Fold provides a software platform that helps primary care teams scale person-centered care through automation, care coordination tools, and patient engagement features. The platform combines clinical operations automation, care team collaboration, and patient-facing portals to improve care outcomes.

3 investors

FORMEL SKIN is a telemedicine platform that provides personalized skincare treatments developed by dermatologists based on photo-based skin analysis. Customers receive customized three-product skincare routines with ongoing medical consultation via chat.

3 investors

Fortell develops AI-powered hearing technology aimed at improving speech clarity and comprehension for people with hearing difficulties. The company operates in the hearing science and clinical care space, working with audiologists, engineers, and hearing experts.

3 investors

Fortuna modernizes the infrastructure and consumer experience for Medicaid and government health programs. The company focuses on improving enrollment, eligibility verification, and access to coverage for Medicaid, CHIP, and Marketplace beneficiaries.

3 investors

Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems. The company serves healthcare providers, researchers, and AI developers seeking trustworthy clinical data integration and analysis.

3 investors

Freespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days. The solution serves health plans, healthcare providers, and self-insured employers seeking to improve patient outcomes and optimize healthcare resource utilization.

3 investors

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health. The company serves reproductive endocrinologists, embryologists, and patients undergoing IVF procedures.

3 investors

Galen Data, Ltd (acquired by Matrix One in December 2024) offers Matrix Connect, a cloud connectivity platform for medical devices that provides a native SDK, web API, configurable dashboards, and compliance frameworks aligned with IEC 62304, HIPAA, GDPR, FDA, and EU MDR. It serves medical device manufacturers and innovators looking to connect devices to the cloud without building custom infrastructure.

3 investors

Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.

3 investors

Gather Health provides primary care services with integrated social and home-based support for older adults in underserved communities. The company operates physical centers that combine medical care with community programs focused on connection, education, and wellness.

3 investors

Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.

3 investors

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.

3 investors

Genie Fertility develops a discovery platform that uses machine learning and multi-omics analysis to identify molecular biomarkers in uterine lining, leveraging menstrual blood samples to improve reproductive health outcomes and fertility diagnostics. The platform aims to address the high failure rate of IVF by providing better understanding of endometrial health, which can account for up to one-quarter of infertility issues.

3 investors

Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations. The company focuses on making its tests inclusive through diverse clinical trials, patient education, and community partnerships.

3 investors

LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.

3 investors

Get Well provides patient and family engagement technology for healthcare providers, now combined with RhythmX AI to bring AI capabilities to its offerings. The company operates in the digital health and patient engagement space.

3 investors

Goally builds a dedicated tablet device and app suite for toddlers and young children (ages 2-8), offering visual schedules, chore charts, reward systems, and interactive lessons for executive function, emotional regulation, speech, life skills, and early education. The closed, ad-free ecosystem is aimed at parents teaching independence and skill-building, including children with developmental needs.

3 investors

GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.

3 investors

GrayMatters Health develops Prism, an interventional psychiatry suite that uses fMRI-informed EEG digital biomarkers and self-neuromodulation to help patients regulate brain activity linked to conditions such as PTSD and depression. It is sold to psychiatry clinics to augment standard-of-care therapies.

3 investors

Greatly Health delivers evidence-based integrative medicine to cancer patients and survivors through virtual classes, one-on-one health coaching, and community support. The program, developed by oncologists and integrative medicine specialists at Memorial Sloan Kettering Cancer Center, combines conventional medical treatments with complementary mind-body therapies to reduce treatment side effects and improve health outcomes.

3 investors

Grit Bio develops nine core technology platforms for cell therapy manufacturing and development, spanning TIL expansion, viral vector production, immunological target discovery, and LNP delivery systems for therapeutic applications.

3 investors

ComplianceAssist is an AI-powered auditing platform for long-term care facilities that monitors electronic health records across 28 clinical domains to identify documentation gaps and compliance risks. The system automatically surfaces issues and routes them to nursing staff with actionable corrections, enabling facilities to resolve compliance deficiencies before regulatory surveys.

3 investors

Hazel Health operates a school-based telehealth platform that connects students with licensed clinicians for healthcare services. The platform serves school districts and families across multiple U.S. states to improve student health access and reduce classroom absences.

3 investors